Sharon Hemond Hrynkow Cyclo Therapeutics, Inc. (CYTH) insider trading activity

Sharon Hemond Hrynkow is Chief Scientific Officer of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 19,350 shares of CYTH, which is worth approximately $13,158. The most recent transaction as insider was on Dec 02, 2021, when has been sold 1,000 shares (Common Stock) at a price of $4.98 per share, resulting in proceeds of $4,980. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.4K

0% 3M change

0% 12M change

Total Value Held $13,158

Sharon Hemond Hrynkow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2021	BUY Open market or private purchase	$4,980 $4.98 p/Share	1,000 Added 4.91%	19,350 Common Stock
Mar 29 2021	BUY Open market or private purchase	$7,460 $7.46 p/Share	1,000 Added 5.17%	18,350 Common Stock
Jan 13 2021	BUY Grant, award, or other acquisition	-	10,000 Added 36.56%	17,350 Common Stock
Dec 11 2020	BUY Grant, award, or other acquisition	-	1,000 Added 11.98%	7,350 Common Stock

Also insider at

FORD

Forward Industries, Inc. Consumer Cyclical

Director

SHH